Budesonide 200 Rotacaps
Price range: $24.00 through $63.65
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 120 Rotacap/s | $24.00 |
|
|
| 240 Rotacap/s | $63.65 |
|
|
| 360 Rotacap/s | $58.80 |
|
SKU : N/A
Category : Asthma
Budesonide Rotacaps contain budesonide, a corticosteroid medication that reduces inflammation in the airways. They are commonly used in the management of asthma and chronic obstructive pulmonary disease (COPD). Budesonide Rotacaps are administered via a Rotahaler device, delivering the medication directly into the lungs to alleviate symptoms such as wheezing and shortness of breath.
| Active Ingredient (Generic Name): | Budesonide |
| Manufacturer: | Cipla Ltd |
| Packaging: | 30 rotacaps in 1 packet |
| Strength: | 200 MCG |
| Delivery Time: | 6 To 15 days |
| SKU: | Budecort 400 Rotacap |
| Pack Size |
120 Rotacap/s ,240 Rotacap/s ,360 Rotacap/s |
|---|
FREE STANDARD SHIPPING on orders of $149 or more
How to get FREE Standard Shipping:
Ship to an address within the United States (including U.S. territories)
Place your online order of $149 or more* – after promotions and before tax are applied
Use “Standard” shipping option at checkout
Orders will be shipped within 24 hours of order placement*, pending verification of billing information and shipping method selected. International orders and orders containing gift cards or items that are not currently in stock will be processed as quickly as possible.
Excludes all orders placed on major US holidays (Memorial Day, Independence Day, Labor Day, Thanksgiving Day, Christmas Day and New Year’s Day).
Orders for states outside of the continental U.S. (including those of $149 or more) may be subject to a delivery surcharge. This will be noted in the order summary based on your shipping address at checkout.
Related products
Asthalin Inhaler
Budesonide 400 Rotacaps
Budesonide Inhaler 100
Clenbuterol 60 MCG
Kaymedorol 4 mg (Methylprednisolone)
Kaymedorol 8 mg (Methylprednisolone)
Nasoclear Salina Nasal Spray
Reviews
There are no reviews yet.